Shallow whole genome sequencing of adenoid cystic carcinomas of the salivary glands identifies specific chromosomal aberrations related to tumor progression-Reference-Cited by-同舟云学术

Shallow whole genome sequencing of adenoid cystic carcinomas of the salivary glands identifies specific chromosomal aberrations related to tumor progression

Published:2020-04 Issue: Volume:103 Page:104615
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Cordesmeyer R.,Laskawi R.,Schliephake H.,Kauffmann P.,Beck J.,Bornemann-Kolatzki K.,Schütz E.,Ströbel P.,Kueffer S.,Fichtner A.,Bremmer F.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference43 articles.

1. Adenoid cystic carcinoma of the head and neck: a review;Bradley;Curr Opin Otolaryngol Head Neck Surgery,2004

2. Adenoid cystic carcinoma of salivary glands. A study of 61 cases with clinicopathologic correlation;Nascimento;Cancer,1986

3. Salivary gland carcinoma in Denmark 1990–2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA);Bjørndal;Oral Oncol,2011

4. Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors;Vander Poorten;Cancer,1999

5. Adenoid cystic carcinoma of the head and neck – an update;Coca-Pelaz;Oral Oncol,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenoid cystic carcinoma: insights from molecular characterization and therapeutic advances;MedComm;2024-09

2. Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications;Frontiers in Oncology;2023-07-05

3. Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer;npj Precision Oncology;2022-07-19

4. Mutational and immunologic Landscape in malignant Salivary Gland Tumors harbor the potential for novel therapeutic strategies;Critical Reviews in Oncology/Hematology;2022-02

5. Salivary gland cancer in the era of immunotherapy: can we exploit tumor microenvironment?;Expert Opinion on Therapeutic Targets;2020-08-30